Autosomal Dominant Polycystic Kidney Disease: 2009 Update for Internists
William M. Bennett
Korean J Intern Med. 2009;24(3):165-168. Published online 2009 Aug 26 DOI: https://doi.org/10.3904/kjim.2009.24.3.165
Citations to this article as recorded by 
Development of a Patient-Reported Outcomes Tool to Assess Pain and Discomfort in Autosomal Dominant Polycystic Kidney Disease
Dorothee Oberdhan, Jason C. Cole, Mark J. Atkinson, Holly B. Krasa, Sara N. Davison, Ronald D. Perrone
Clinical Journal of the American Society of Nephrology.2023; 18(2): 213. CrossRef
Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of
autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period
Hyuk Huh, Yong Soo Kim, Wookyung Chung, Yong Lim Kim, Yaerim Kim, Seungyeup Han, Yeonsoon Jung, Ki Young Na, Kyu Beck Lee, Yun Kyu Oh, Hyeong Cheon Park, Seung Hyeok Han, Tae Hyun Yoo, Yeong Hoon Kim, Soo Wan Kim, Kang Wook Lee, Hayne Cho Park, Sung Gyun
Kidney Research and Clinical Practice.2023; 42(2): 216. CrossRef
37-Year-Old Woman With Bilateral Lower Extremity Edema, Proteinuria, and Microscopic Hematuria
Jennifer J. Gile, Benjamin A. Satterfield, Emily L. Leasure
Mayo Clinic Proceedings.2020; 95(8): e81. CrossRef
Prevalence, risk factors and disease knowledge of polycystic kidney disease in Pakistan
Rabia Zahid, Muhammad Akram, Ejaz Rafique
International Journal of Immunopathology and Pharmacology.2020; 34: 205873842096608. CrossRef
Actualización en enfermedad renal poliquística
Andrea Montaña, Nasly Patiño, Carolina Larrate, Fanny Andrea Zambrano, Jaime Martínez, Harvey Lozano, Eyner Lozano
Revista de la Facultad de Medicina.2018; 66(1): 107. CrossRef
Lansoprazole reduces renal cyst in polycystic kidney disease via inhibition of cell proliferation and fluid secretion
Jiriporn Nantavishit, Varanuj Chatsudthipong, Sunhapas Soodvilai
Biochemical Pharmacology.2018; 154: 175. CrossRef
Actualización en enfermedad renal poliquística
Andrea Montaña, Nasly Patiño, Carolina Larrate, Fanny Andrea Zambrano, Jaime Martínez, Harvey Lozano, Eyner Lozano
Revista de la Facultad de Medicina.2018; 66(1): 107. CrossRef
Polycystic kidney and liver disease: A diagnostic challenge
M. Alves, A. Miranda, M. Narciso, T. Fonseca
Revista Clínica Española.2015; 215(1): 64. CrossRef
Recent Advances in the Management of Autosomal Dominant Polycystic Kidney Disease
Hayne Park, Young-Hwan Hwang
The Korean Journal of Medicine.2015; 89(2): 169. CrossRef
ADPKD: Prototype of Cardiorenal Syndrome Type 4
Grazia Maria Virzì, Valentina Corradi, Anthi Panagiotou, Fiorella Gastaldon, Dinna N. Cruz, Massimo de Cal, Maurizio Clementi, Claudio Ronco
International Journal of Nephrology.2011; 2011: 1. CrossRef
Glomerular Hyperfiltration and Renal Progression in Children with Autosomal Dominant Polycystic Kidney Disease
Imed Helal, Berenice Reed, Kim McFann, Xiang-Dong Yan, Godela M. Fick-Brosnahan, Melissa Cadnapaphornchai, Robert W. Schrier
Clinical Journal of the American Society of Nephrology.2011; 6(10): 2439. CrossRef
Reduced Methotrexate Clearance and Renal Impairment in a Boy With Osteosarcoma and Earlier Undetected Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Martin Alberer, Julia Hoefele, Carsten Bergmann, Steffen Hartrampf, Jutta Hilberath, Ingo Pawlita, Michael H. Albert, Marcus R. Benz, Lutz T. Weber, Irene Schmid
Journal of Pediatric Hematology/Oncology.2010; 32(8): e314. CrossRef